Topics

Gliomas | Treatment | Side-effects | Bevacizumab

Home > Publications > Topics > Gliomas > Treatment > Side-effects > Bevacizumab

Wei S, Chang L, Zhong Y.
The efficacy and adverse events of bevacizumab combined with temozolomide in the treatment of glioma: a systemic review and meta-analysis of randomized controlled trials.
Front Med (Lausanne). 2024 Jul 2;11:1419038. doi: 10.3389/fmed.2024.1419038. PMID: 39015784. Review; Meta-analysis. ˍ

Wang C, Duan L, Zhao Y, Wang Y, Li Y.
Efficacy and safety of bevacizumab combined with temozolomide in the treatment of glioma a systematic review and meta-analysis of clinical trials.
World Neurosurg. 2024 Oct 24:S1878-8750(24)01775-3? doi: 10.1016/j.wneu.2024.10.071? PMID: 39461419. Review; Meta-analysis˰ ˍ

Gao M, Chen Q, Zhang H, Tian Y, Fu Z, Yan M, Liu C.
Real-world adverse event profile and signal characteristics of bevacizumab in glioma: a FAERS-based disproportionality analysis.
Front Pharmacol. 2026 Jan 13;16:1705451. doi: 10.3389/fphar.2025.1705451. PMID: 41608019. Observational study. ˍ